Evidence map›Paper›PMID 42253857›Full record

ArticleRadiology case reports2026

Abscopal effect in a biopsy-proven chromophobe renal cell carcinoma before planned cryoablation.

Hamza Furmli, Abdullah Alenezi, Syed Naqvi

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hamza FurmliSchulich School of Medicine & Dentistry, Western University/London Health Sciences Centre, London, Ontario, Canada.
Abdullah AleneziInterventional Radiologist, Windsor Regional Hospital, Windsor, Ontario, Canada.
Syed NaqviNeuroradiologist, Windsor Regional Hospital, Windsor, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The abscopal effect, defined as regression of untreated tumors following localized therapy, is rare in renal cell carcinoma (RCC). We present a case of a 49-year-old male who was incidentally found to have a 1.2 cm enhancing mass in the medial lower pole of the left kidney. MRI confirmed a small solid neoplasm, and percutaneous biopsy confirmed histopathological chromophobe RCC diagnosis. The patient was scheduled for cryoablation. On pre-procedural multiphasic CT, the lesion had completely regressed, leaving only a 6 mm cortical scar without enhancement. Cryoablation was aborted, and the patient was placed on active surveillance. This case illustrates the abscopal effect in primary RCC, likely triggered by biopsy as the inciting local event. Recognition of this rare immune-mediated phenomenon emphasizes the importance of confirmatory imaging before intervention and highlights the evolving interplay between radiology, minimally invasive procedures, and tumor immunology.

Indexed as

Abscopal effectBiopsyChromophobeCryoablationImmunologyRenal cell carcinoma

Identifiers

PMID42253857
PMCPMC13233512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.